Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Invested Capital (2016 - 2025)

PAVmed has reported Invested Capital over the past 6 years, most recently at $33.4 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 25.54% year-over-year to $33.4 million; the TTM value through Dec 2025 reached $33.4 million, up 25.54%, while the annual FY2025 figure was $33.4 million, 25.54% up from the prior year.
  • Invested Capital for Q4 2025 was $33.4 million at PAVmed, down from $39.4 million in the prior quarter.
  • Over five years, Invested Capital peaked at $79.4 million in Q4 2021 and troughed at -$570000.0 in Q2 2023.
  • A 5-year average of $40.1 million and a median of $37.3 million in 2021 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: crashed 100.8% in 2023 and later soared 4548.77% in 2024.
  • Year by year, Invested Capital stood at $79.4 million in 2021, then crashed by 43.86% to $44.6 million in 2022, then tumbled by 54.73% to $20.2 million in 2023, then skyrocketed by 31.83% to $26.6 million in 2024, then increased by 25.54% to $33.4 million in 2025.
  • Business Quant data shows Invested Capital for PAVM at $33.4 million in Q4 2025, $39.4 million in Q3 2025, and $35.0 million in Q2 2025.